AR004395A1 - Tableta de liberación rápida comprendiendo ácido tolfenámico o una sal farmacéuticamente aceptable del mismo como ingrediente activo y un método para la preparación de dicha tableta. - Google Patents

Tableta de liberación rápida comprendiendo ácido tolfenámico o una sal farmacéuticamente aceptable del mismo como ingrediente activo y un método para la preparación de dicha tableta.

Info

Publication number
AR004395A1
AR004395A1 ARP960105763A ARP960105763A AR004395A1 AR 004395 A1 AR004395 A1 AR 004395A1 AR P960105763 A ARP960105763 A AR P960105763A AR P960105763 A ARP960105763 A AR P960105763A AR 004395 A1 AR004395 A1 AR 004395A1
Authority
AR
Argentina
Prior art keywords
tablet
pharmaceutically acceptable
active ingredient
acceptable salt
quick release
Prior art date
Application number
ARP960105763A
Other languages
English (en)
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of AR004395A1 publication Critical patent/AR004395A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una tableta de liberación rápida comprendiendo un ingrediente activo, seleccionado de ácido tolfenámico y sales farmacéuticamente aceptables. Elingrediente activo tiene una tamano medio de partículas de </= 10 micrones. La tableta comprende ácidoalgínico o una sal farmacéuticamente aceptable delmismo en una cantidad de 1,5 - 6,0% por peso y un superdesintegrante en una cantidad de por lo menos 6% por peso.
ARP960105763A 1995-12-20 1996-12-18 Tableta de liberación rápida comprendiendo ácido tolfenámico o una sal farmacéuticamente aceptable del mismo como ingrediente activo y un método para la preparación de dicha tableta. AR004395A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK144895 1995-12-20

Publications (1)

Publication Number Publication Date
AR004395A1 true AR004395A1 (es) 1998-11-04

Family

ID=8104933

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105763A AR004395A1 (es) 1995-12-20 1996-12-18 Tableta de liberación rápida comprendiendo ácido tolfenámico o una sal farmacéuticamente aceptable del mismo como ingrediente activo y un método para la preparación de dicha tableta.

Country Status (27)

Country Link
US (1) US6036975A (es)
EP (1) EP0869783B1 (es)
JP (1) JP2000515489A (es)
CN (1) CN1147295C (es)
AR (1) AR004395A1 (es)
AT (1) ATE234085T1 (es)
AU (1) AU1190097A (es)
BR (1) BR9612057A (es)
CA (1) CA2244396A1 (es)
CZ (1) CZ293422B6 (es)
DE (1) DE69626676T2 (es)
DK (1) DK0869783T3 (es)
EE (1) EE9800186A (es)
ES (1) ES2191781T3 (es)
HR (1) HRP960598A2 (es)
HU (1) HU224030B1 (es)
IL (1) IL124356A (es)
MX (1) MX9803918A (es)
NO (1) NO316869B1 (es)
NZ (1) NZ324674A (es)
PL (1) PL186915B1 (es)
RO (1) RO117589B1 (es)
RU (1) RU2166939C2 (es)
TR (1) TR199801126T2 (es)
TW (1) TW430561B (es)
WO (1) WO1997022340A1 (es)
ZA (1) ZA9610714B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
US6660303B2 (en) * 1999-12-06 2003-12-09 Edward Mendell & Co. Pharmaceutical superdisintegrant
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
WO2005028621A2 (en) * 2003-09-15 2005-03-31 Vitra Bioscience, Inc. Assays with primary cells
WO2007112098A2 (en) * 2006-03-24 2007-10-04 The Texas A & M University System And Safe Et Al Uses of diphenyl/diphenylamine carboxylic acids
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
CA3036053A1 (en) * 2016-09-07 2018-03-15 Celgene Corporation Tablet compositions
CN111184707B (zh) * 2020-02-20 2021-04-27 中山大学 托芬那酸或其药学上可接受的盐在制备预防和/或治疗新型冠状病毒炎症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE116061C (es) *
FI89004C (fi) * 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale

Also Published As

Publication number Publication date
PL327584A1 (en) 1998-12-21
AU1190097A (en) 1997-07-14
CZ194398A3 (cs) 1998-11-11
TR199801126T2 (xx) 1998-08-21
HU224030B1 (hu) 2005-05-30
IL124356A0 (en) 1998-12-06
IL124356A (en) 2001-05-20
ATE234085T1 (de) 2003-03-15
NO316869B1 (no) 2004-06-07
EP0869783A1 (en) 1998-10-14
CN1208345A (zh) 1999-02-17
PL186915B1 (pl) 2004-03-31
HUP9903410A3 (en) 2000-05-29
ES2191781T3 (es) 2003-09-16
JP2000515489A (ja) 2000-11-21
CA2244396A1 (en) 1997-06-26
NO982875L (no) 1998-08-19
BR9612057A (pt) 1999-02-23
DE69626676T2 (de) 2003-12-18
NZ324674A (en) 2000-01-28
HUP9903410A2 (hu) 2000-04-28
RO117589B1 (ro) 2002-05-30
NO982875D0 (no) 1998-06-19
CN1147295C (zh) 2004-04-28
RU2166939C2 (ru) 2001-05-20
WO1997022340A1 (en) 1997-06-26
EE9800186A (et) 1998-12-15
HRP960598A2 (en) 1998-02-28
MX9803918A (es) 1998-09-30
EP0869783B1 (en) 2003-03-12
DE69626676D1 (de) 2003-04-17
US6036975A (en) 2000-03-14
ZA9610714B (en) 1997-06-30
CZ293422B6 (cs) 2004-04-14
TW430561B (en) 2001-04-21
DK0869783T3 (da) 2003-06-02

Similar Documents

Publication Publication Date Title
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
AR037629A1 (es) Formulaciones farmaceuticas que comprenden un derivado de platino
ES2052016T3 (es) Composicion emulsionada.
AR033688A1 (es) Composicion parenteral reconstituible
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
CO4290417A1 (es) Nuevas benzoilguanidinas como medicamentos y su preparacion .
UY26372A1 (es) &#34;imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen &#34;
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
TR199903053T2 (xx) Benzimidazol t�revleri.
BR0112311A (pt) Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso
CO5261536A1 (es) Composicion de liberacion modificada multiparticulada
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
MX9304675A (es) Composicion farmaceutica solida en forma de dosis, que tiene un perfil de liberacion extendido, de dos etapas y proceso para su preparacion.
AR004395A1 (es) Tableta de liberación rápida comprendiendo ácido tolfenámico o una sal farmacéuticamente aceptable del mismo como ingrediente activo y un método para la preparación de dicha tableta.
ES2058892T3 (es) Uso de omeprazol como agente antimicrobiano.
ES2098920T3 (es) Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
DE59908764D1 (de) Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung
AR061005A2 (es) Forma cristalina a de 1-(2,6- difluorobencil)-1h-1,2,3- triazol-4-carboxamida, preparaciones farmaceuticas que las contienen y su uso para la preparacion de medicamentos
CO5070657A1 (es) Composiciones farmaceuticas para tratar infecciones virales y metodo para hacerlas
DE60313296D1 (de) Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten
GB2334446B (en) Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use
ATE375789T1 (de) Orales abgabesystem mit einem antibakteriellen und einem entzündungshemmenden mittel
CO5560554A2 (es) Composicion farmaceutica que comprende lumiracoxib
AR018376A1 (es) Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento

Legal Events

Date Code Title Description
FG Grant, registration